Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 650 of 3284 entries
View as:

LYNPARZA Breast Cancer in the Adjuvant Setting Japan Post-Marketing Surveillance (PMS)

Phase: N/A Priority: Normal
NCT ID: NCT05677308 Org: User:
Start: 03/07/23 End: 12/31/26 Due: 12/31/27

A Study to Assess the Safety, Tolerability and Pharmacokinetics After Single Ascending Intravenous Doses of AZD2927 in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01264250 Org: User:
Start: 01/31/11 End: 05/31/11 Due: 05/31/12

Postoperative Radiotherapy Plus Iressa or Radiotherapy Plus Cisplatin and Iressa for Advanced Head & Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00681967 Org: User:
Start: 02/29/04 End: 10/31/09 Due: 10/31/10

Real-World Treatment Patterns and Patient Reported Outcome in COPD (REMIND)

Phase: N/A Priority: Normal
NCT ID: NCT05903989 Org: User:
Start: 09/11/23 End: 10/24/23 Due: 10/24/24

Observational Study on Costs and Caregiver Burden in Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00698165 Org: User:
Start: 06/30/07 End: 01/31/09 Due: 01/31/10

Savolitinib Plus Durvalumab Versus Sunitinib and Durvalumab Monotherapy in MET-Driven, Unresectable and Locally Advanced or Metastatic PRCC

Phase: N/A Priority: Normal
NCT ID: NCT05043090 Org: User:
Start: 10/28/21 End: 10/30/25 Due: 10/30/26

Osimertinib Plus Savolitinib in EGFRm+/MET+ NSCLC Following Prior Osimertinib

Phase: N/A Priority: Normal
NCT ID: NCT03778229 Org: User:
Start: 01/09/19 End: 05/28/25 Due: 05/28/26

What is the Predictive Value of the Reflux Impact Scale

Phase: N/A Priority: Normal
NCT ID: NCT00536328 Org: User:
Start: 10/31/07 End: 06/30/08 Due: 06/30/09

Gastroprotective Agent Utilization and Compliance in Patients > 60 Years Taking Low-dose Aspirin in France

Phase: N/A Priority: Normal
NCT ID: NCT01238809 Org: User:
Start: 06/30/11 End: 07/31/11 Due: 07/31/12

Assessment of Endometrial Changes in Postmenopausal Women With Breast Cancer in Adjuvant Treatment With Anastrozole

Phase: N/A Priority: Normal
NCT ID: NCT00623519 Org: User:
Start: 06/30/04 End: 02/28/09 Due: 02/28/10

Iressa Case Control Study in Japan

Phase: N/A Priority: Normal
NCT ID: NCT00252759 Org: User:
Start: 11/30/03 End: 02/28/06 Due: 02/28/07

InPractice Survey on the Treatment of Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT00523796 Org: User:
Start: 02/28/07 End: 11/30/07 Due: 11/30/08

Study of Durvalumab Given With Chemoradiation Therapy in Patients With Unresectable Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03519971 Org: User:
Start: 03/29/18 End: 03/31/25 Due: 03/31/26

Acute Kidney Injury in Patients on Dapagliflozin and Other Antidiabetic Medications

Phase: N/A Priority: Normal
NCT ID: NCT02695082 Org: User:
Start: 01/01/17 End: 11/30/20 Due: 11/30/21

To Evaluate Effectiveness of Aclidinium Bromide/Formoterol Fumarate Dihydrate in Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT03181880 Org: User:
Start: 12/04/17 End: 12/03/18 Due: 12/03/19

HEARD (Long Term) Study - Histology of the Esophagus in Acid-Related Disease

Phase: N/A Priority: Normal
NCT ID: NCT00243724 Org: User:
Start: 04/30/05 End: 06/30/07 Due: 06/30/08

A Study to Assess Safety and Tolerability of Oral AZD3241 in Patients With Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01603069 Org: User:
Start: 10/31/12 End: 06/30/13 Due: 06/30/14

ATEM (Alvesco Non-interventional Study)

Phase: N/A Priority: Normal
NCT ID: NCT01147224 Org: User:
Start: 03/31/10 End: 08/31/11 Due: 08/31/12

Study of Efficacy and Safety of Seroquel (Quetiapine Fumarate) as Mono-Therapy for Acute Schizophrenic

Phase: N/A Priority: Normal
NCT ID: NCT00428350 Org: User:
Start: 12/31/06 End: 09/30/07 Due: 09/30/08

Efficacy and Safety of Seroquel and Lithium as Monotherapy in Acute Mania Treatment in Bipolar Disorder Patients

Phase: N/A Priority: Normal
NCT ID: NCT00448578 Org: User:
Start: 08/31/05 End: 06/30/06 Due: 06/30/07

A Study to Investigate the Effect of Roxadustat Versus Recombinant Human Erythropoietin (rHuEPO) on Oral Iron Absorption in Chinese Patients With Anemia of Chronic Kidney Disease (CKD)

Phase: N/A Priority: Normal
NCT ID: NCT04655027 Org: User:
Start: 02/22/21 End: 10/12/21 Due: 10/12/22

GALLANT 8 Tesaglitazar Add-on to Metformin

Phase: N/A Priority: Normal
NCT ID: NCT00251953 Org: User:
Start: 07/31/04 End: 03/31/06 Due: 03/31/07

Long Term Safety of Anifrolumab in Adult Subjects With Active Systemic Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT02794285 Org: User:
Start: 06/30/16 End: 12/21/21 Due: 12/21/22

A Bioavailability Study Comparing Modified-release Capsules and Immediate Release Capsules in Fed and Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01092299 Org: User:
Start: 02/28/10 End: 07/31/10 Due: 07/31/11

Drug Interaction With Metformin

Phase: N/A Priority: Normal
NCT ID: NCT00546741 Org: User:
Start: 11/30/07 End: 02/29/08 Due: 02/28/09